<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00918372</url>
  </required_header>
  <id_info>
    <org_study_id>img001</org_study_id>
    <nct_id>NCT00918372</nct_id>
  </id_info>
  <brief_title>Coronary Artery Disease (CAD) in Women Marathon Runners</brief_title>
  <official_title>Coronary Atherosclerosis in Women Athletes: Asymptomatic Twin Cities Marathon Women Studied by MSCT Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minneapolis Heart Institute Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Minneapolis Heart Institute Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the effects of extreme fitness in women. The incidence
      of coronary artery disease observed via multislice computed tomography (MSCT) angiogram will
      be compared with age and risk-matched controls from both sedentary and fitness activity
      groups who have never been significant runners. Life style, training volume and risk factors
      will be assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single-center, non-randomized, prospective, observational study. The study population will be
      up to 100 female athletes who are competitive long distance runners, and have been so for a
      minimum of 10 years. Multi-slice computed tomography (MSCT) will be used to characterize the
      amount, severity and type of atherosclerotic lesions. MSCTA will be performed per usual
      practice using a minimum X-ray dose protocol.

      The study will determine whether moderate to high intensity, long term athletic training and
      competition is associated with enhanced coronary artery disease in women. Each participant
      will complete a life-style, training volume and risk factor questionnaire. These participants
      will be compared to an age, gender and risk factor matched cohort.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of coronary artery disease confirmed by Multislice Computed Tomography</measure>
    <time_frame>At enrollment</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Extreme fitness</arm_group_label>
    <description>Female competitive long distance runners</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Age and Risk matched controls</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Female long distance runners as compared to age and risk-matched controls from both
        sedentary and fitness activity groups who have never been significant runners, derived from
        the Minneapolis Heart Institute Foundation's (MHIF) Cross-Sectional Imaging database.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female athletes who have run marathons competitively for a minimum of 10 years.

          -  Age &gt; 40 years old

          -  Agree to participate and sign an informed consent form

        Exclusion Criteria:

          -  Allergy to X-ray contrast

          -  Creatinine ≥ 2.0

          -  Pregnant Female

          -  Has run a marathon within the past 2 weeks
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert S Schwartz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minneapolis Heart Institute Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Minneapolis Heart Institute at Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mplsheart.org/</url>
    <description>The Minneapolis Heart Institute Foundation improves cardiovascular health through clinical research and education</description>
  </link>
  <link>
    <url>http://www.mplsheart.com</url>
    <description>The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care</description>
  </link>
  <reference>
    <citation>Angeli SJ, Haft JI. Severe coronary artery disease in a marathon runner. Chest. 1987 Feb;91(2):271-2.</citation>
    <PMID>3802941</PMID>
  </reference>
  <reference>
    <citation>Bassler TJ. Coronary-artery disease in marathon runners. N Engl J Med. 1980 Jan 3;302(1):57-8.</citation>
    <PMID>7350403</PMID>
  </reference>
  <reference>
    <citation>Colt E. Coronary-artery disease in marathon runners. N Engl J Med. 1980 Jan 3;302(1):57.</citation>
    <PMID>7350401</PMID>
  </reference>
  <reference>
    <citation>Goel R, Majeed F, Vogel R, Corretti MC, Weir M, Mangano C, White C, Plotnick GD, Miller M. Exercise-induced hypertension, endothelial dysfunction, and coronary artery disease in a marathon runner. Am J Cardiol. 2007 Mar 1;99(5):743-4. Epub 2007 Jan 11.</citation>
    <PMID>17317385</PMID>
  </reference>
  <reference>
    <citation>Handler JB, Asay RW, Warren SE, Shea PM. Symptomatic coronary artery disease in a marathon runner. JAMA. 1982 Aug 13;248(6):717-9.</citation>
    <PMID>7097925</PMID>
  </reference>
  <reference>
    <citation>Hellerstein HK, Moir TW. Distance running in the 1980s: cardiovascular benefits and risks. Cardiovasc Clin. 1985;15(2):75-86. Review.</citation>
    <PMID>3912053</PMID>
  </reference>
  <reference>
    <citation>Lehtonen A, Viikari J. Coronary-artery disease in marathon runners. N Engl J Med. 1980 Jan 3;302(1):57.</citation>
    <PMID>7350402</PMID>
  </reference>
  <reference>
    <citation>Maron BJ, Poliac LC, Roberts WO. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol. 1996 Aug;28(2):428-31.</citation>
    <PMID>8800121</PMID>
  </reference>
  <reference>
    <citation>Möhlenkamp S, Böse D, Mahabadi AA, Heusch G, Erbel R. On the paradox of exercise: coronary atherosclerosis in an apparently healthy marathon runner. Nat Clin Pract Cardiovasc Med. 2007 Jul;4(7):396-401.</citation>
    <PMID>17589430</PMID>
  </reference>
  <reference>
    <citation>Möhlenkamp S, Schmermund A, Kröger K, Kerkhoff G, Bröcker-Preuss M, Adams V, Hensel M, Kiefer D, Lehmann N, Moebus S, Leineweber K, Elsenbruch S, Barkhausen J, Halle M, Hambrecht R, Siegrist J, Mann K, Budde T, Jöckel KH, Erbel R. Coronary atherosclerosis and cardiovascular risk in masters male marathon runners. Rationale and design of the &quot;marathon study&quot;. Herz. 2006 Sep;31(6):575-85.</citation>
    <PMID>17036189</PMID>
  </reference>
  <reference>
    <citation>Neilan TG, Januzzi JL, Lee-Lewandrowski E, Ton-Nu TT, Yoerger DM, Jassal DS, Lewandrowski KB, Siegel AJ, Marshall JE, Douglas PS, Lawlor D, Picard MH, Wood MJ. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation. 2006 Nov 28;114(22):2325-33. Epub 2006 Nov 13.</citation>
    <PMID>17101848</PMID>
  </reference>
  <reference>
    <citation>Noakes TD. Heart disease in marathon runners: a review. Med Sci Sports Exerc. 1987 Jun;19(3):187-94. Review.</citation>
    <PMID>3298928</PMID>
  </reference>
  <reference>
    <citation>Roberts WO, Maron BJ. Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol. 2005 Oct 4;46(7):1373-4.</citation>
    <PMID>16198859</PMID>
  </reference>
  <reference>
    <citation>Schuchert A, Püschel K, Kupper W, Schäfer H, Bleifeld W. [Sudden heart death in a long distance runner during a marathon]. Z Kardiol. 1989 Apr;78(4):276-80. German.</citation>
    <PMID>2735089</PMID>
  </reference>
  <reference>
    <citation>Rowe WJ. A world record marathon runner with silent ischemia without coronary atherosclerosis. Chest. 1991 May;99(5):1306-8.</citation>
    <PMID>2019205</PMID>
  </reference>
  <reference>
    <citation>Tunstall Pedoe DS. Marathon cardiac deaths : the london experience. Sports Med. 2007;37(4-5):448-50.</citation>
    <PMID>17465632</PMID>
  </reference>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2009</study_first_submitted>
  <study_first_submitted_qc>June 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2009</study_first_posted>
  <last_update_submitted>September 10, 2010</last_update_submitted>
  <last_update_submitted_qc>September 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Robert Stockton Schwartz</name_title>
    <organization>Minneapolis Heart Institute Foundation</organization>
  </responsible_party>
  <keyword>MSCTA</keyword>
  <keyword>Marathon runners</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

